As diabetes care continues to be a significant focus, innovative treatments are emerging . Retatrutide, Tirzepatide, and Semaglutide represent a noteworthy evolution in GLP-1 receptor agonist medications. While https://sociallweb.com/story7730019/retatrutide-vs-tirzepatid-vs-this-injection-a-head-to-head-look